发明名称 |
Prenylarene compound and use thereof |
摘要 |
A compound represented by the general formula (C):;
(wherein R101 represents a substituted or unsubstituted aromatic heterocyclic group,
R102, R103, R104 and R105 may be the same or different, and each represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 3 carbon atoms, or a haloalkyl group having 1 to 3 carbon atoms, andR106 represents a hydrogen atom, or a saturated or unsaturated hydrocarbon group which is a straight or branched chain having 1 to 12 carbon atoms, butexcluded is the case where R101 is a 3-furyl group, R102, R103, R104 and R105 are all methyl groups, and R106 is a methyl group, a 4-methyl-3-pentenyl group or a 4,8-dimethyl-3,7-nonadienyl group); ora pharmaceutically acceptable salt thereof has selective inhibitory activity on hypoxic cell growth in a broad range of the concentration and therefore is useful as an active ingredient of a medicament for cancer prevention or treatment. |
申请公布号 |
US9371301(B2) |
申请公布日期 |
2016.06.21 |
申请号 |
US201113696425 |
申请日期 |
2011.05.06 |
申请人 |
Osaka University |
发明人 |
Kobayashi Motomasa;Kotoku Naoyuki;Arai Masayoshi;Kawachi Takashi |
分类号 |
C07D307/36;C07D333/06;A61K31/341;A61K31/381;A61K45/06;C07D333/08 |
主分类号 |
C07D307/36 |
代理机构 |
Wenderoth, Lind & Ponack, L.L.P. |
代理人 |
Wenderoth, Lind & Ponack, L.L.P. |
主权项 |
1. A compound represented by the general formula (C): wherein R101 represents a substituted or unsubstituted furyl group or a substituted or unsubstituted thienyl group, R102 , R103 , R104 and R105 may be the same or different, and each represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 3 carbon atoms, or a haloalkyl group having 1 to 3 carbon atoms, and R106 represents a hydrogen atom, or a saturated or unsaturated hydrocarbon group which is a straight or branched chain having 1 to 12 carbon atoms, but excluded is the case where when R101 is a 3-furyl group, and R102, R103, R104 and R105 are all methyl groups, R106 is not a methyl group, a 4-methyl-3-pentenyl group or a 4,8-dimethyl-3,7-nonadienyl group; or a pharmaceutically acceptable salt thereof. |
地址 |
Osaka JP |